603108.SS SHH
Shanghai Runda Medical Technology Co., Ltd.
1W: -2.0%
1M: +1.0%
3M: +7.2%
YTD: -40.0%
1Y: -45.7%
3Y: -31.7%
5Y: -7.1%
¥9.97 ($1.49)
-0.11 (-1.09%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$647M
-11.3% ▼
5Y CAGR: +21.3%
Capital Expenditures
$229M
+28.4% ▲
5Y CAGR: -4.5%
Free Cash Flow
$418M
+1.9% ▲
Dividends Paid
$337M
+10.6% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$276M
+61.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $504M | $598M | $655M | $273M | $189M |
| Depreciation & Amort. | $303M | $365M | $384M | $375M | $394M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$673M | -$844M | -$1.9B | -$331M | -$255M |
| Other Non-Cash Items | $190M | $251M | $438M | $487M | $318M |
| Operating Cash Flow | $323M | $371M | -$429M | $802M | $647M |
| — Investing Activities — | |||||
| Capital Expenditures | -$332M | -$301M | -$272M | -$320M | -$229M |
| Acquisitions (Net) | -$418M | -$161M | -$25M | -$23M | -$184K |
| Investment Purchases | -$1.8B | -$1.0B | -$773M | -$556M | -$573M |
| Investment Sales | $1.5B | $1.1B | $716M | $652M | $401M |
| Other Investing | $14M | $20M | $31M | -$49M | -$59M |
| Investing Cash Flow | -$1.0B | -$415M | -$323M | -$296M | -$461M |
| — Financing Activities — | |||||
| Net Debt Issuance | $1.0B | $702M | $864M | $16M | $372M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$226M | -$66M | -$66M | -$378M | -$337M |
| Other Financing | -$3M | -$334M | -$310M | $26M | $57M |
| Financing Cash Flow | $806M | $95M | $488M | -$335M | $92M |
| Net Change in Cash | $115M | $50M | -$263M | $171M | $276M |
| Cash End of Period | $655M | $705M | $442M | $613M | $889M |
| Free Cash Flow | -$8M | $70M | -$701M | $410M | $418M |